Radcliffe Capital Management’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Radcliffe Capital Management’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-736,285	Closed	-$7.26M	–	1076
2022 Q3	$7.26M	Buy	736,285 +126,500	+21%	+$1.25M	0.18%	135
2022 Q2	$5.98M	Buy	609,785 +11,501	+2%	+$113K	0.14%	196
2022 Q1	$5.87M	Buy	598,284 +64,760	+12%	+$632K	0.13%	172
2021 Q4	$5.2M	Hold	533,524	–	–	0.14%	148
2021 Q3	$5.18M	Hold	533,524	–	–	0.15%	127
2021 Q2	$5.18M	Buy	+533,524	New	+$5.22M	0.16%	124

Radcliffe Capital Management's SSAA Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 736,285 shares — an estimated $7.26M sold.

Radcliffe Capital Management first reported a position in SSAA in Q2 2021 and held it in 6 quarters. The position peaked at $7.26M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Radcliffe Capital Management reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 736,285 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $7.26M.
Radcliffe Capital Management first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 6 quarters.
Radcliffe Capital Management's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $7.26M in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.